Показано 0 из 0
Дата |
---|
20.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.70
|
4.86
|
4.90
|
4.90
|
4.90
|
4.90
|
|
|
|
|
4.81
|
4.96
|
4.94
|
4.94
|
4.94
|
4.94
|
|
|
|
|
4.88
|
5.06
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.78
|
4.97
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.71
|
4.92
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.75
|
4.94
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.80
|
4.94
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.80
|
4.92
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.82
|
4.95
|
4.89
|
4.89
|
4.89
|
4.89
|
|
|
|
|
4.81
|
4.99
|
5.04
|
5.04
|
5.04
|
5.04
|
|
|
|
|
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Europe, and Germany.